Jones Financial Companies
ATYR

Jones Financial Companies’s aTyr Pharma ATYR Stock Holding History

Jones Financial Companies’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791 Hold
1,500
– – ﹤0.01% 4656
2026
Q1 		$1.13K Hold
1,500
– – ﹤0.01% 4320
2025
Q4 		$1.18K Buy
+1,500
New +$1.23K ﹤0.01% 3974

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies's ATYR Position: Q2 2026 in Review

Jones Financial Companies held its aTyr Pharma (ATYR) position steady in Q2 2026 at 1,500 shares worth $791. The position accounts for ﹤0.01% of the portfolio, ranked #4656.

Jones Financial Companies first reported a position in ATYR in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.18K in Q4 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Jones Financial Companies held 1,500 shares of aTyr Pharma worth $791 as of Q2 2026.
  • Jones Financial Companies left its aTyr Pharma share count unchanged in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4656 holding.
  • Jones Financial Companies first reported a position in aTyr Pharma in Q4 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's aTyr Pharma position peaked at $1.18K in Q4 2025.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.